Table 1.
Age, sex and PARK2 genotype of the donors of the blood macrophages used in this study
| Age (years) | Sex | PARK2 mutation | |
|---|---|---|---|
| Control subject 1 | 44 | M | No mutation |
| Control subject 2 | 40 | M | No mutation |
| Control subject 3 | 30 | M | No mutation |
| Control subject 4 | 39 | F | No mutation |
| Control subject 5 | 49 | F | No mutation |
| PARK2 PD Patient 1 | 31 | M | c.[(412 + 1_413‐1)_(734 + 1_735‐1)del];[633A>T] |
| PARK2 PD Patient 2 | 41 | M | c.[673delG];[673delG] |
| PARK2 PD Patient 3 | 44 | M | c.[673delG];[673delG] |
| PARK2 PD Patient 4 | 33 | M | c.[(534 + 1_535‐1)_(618 + 1_619‐1)del];[155delA] |
| PARK2 PD Patient 5 | 30 | F | c.[(7 + 1_8‐1)_(171 + 1_172‐1)del];[827delA] |
| PARK2 PD Patient 6 | 37 | F | c.[(171 + 1_172‐1)_(534 + 1_535‐1)del]; c.[(171 + 1_172‐1)_(534 + 1_535‐1)del] |